NPI registry status
Active
2026 NPPES data Retina Specialist (Ophthalmology) Physician NPI 1902895998 M.D.
Verify on CMS → Alan Uliss, M.D.
Retina Specialist (Ophthalmology) Physician in Forest Hills, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 983 in Retina Specialist (Ophthalmology) Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
4K
Medicare Part D claims · 831 beneficiaries · Retina Specialist (Ophthalmology) Physician avg: 593
Generic prescribing
56%
generic claims · 44% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
CMS neutral threshold · no category scores published
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Alan Uliss, M.D. carries the neutral CMS MIPS final score of 75/100, assigned where no category was scored - and filed 4,190 Medicare Part D claims in 2024.
- 75/100
- CMS neutral score · not measured
- 4K
- Part D claims, 2024
- 56%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Alan Uliss, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1902895998), first enumerated 10/21/2005.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 4,190 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
CMS assigned a neutral MIPS final score of 75/100 where no performance category was scored — not a measured quality rank.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- State context
State board disciplinary context
New York statewide board action statistics are published annually — these figures describe aggregate state activity, not Alan Uliss, M.D.'s individual license status. Verify directly with the state medical board.
Source: NYSBPMC annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1902895998 · Retina Specialist (Ophthalmology) Physician
NPI-10 · ENUM-LEGACY · TAX-NARROW · MIPS-NEUTRAL · RX-MID · BOOK-THIN · PHOTO-ENUM
- NPI-10 1902895998
- ENUM-LEGACY 2005
- TAX-NARROW 983
- MIPS-NEUTRAL 75/100
- RX-MID 4,190
- BOOK-THIN 74 in New York
- PHOTO-ENUM Mari Keithahn, M.D. · 2005
Alan Uliss, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
4,190 ≥ 92nd percentile 92% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Alan Uliss, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Alan Uliss, M.D.?
CMS neutral score, not measuredPrimary specialty
Retina Specialist (Ophthalmology) Physician
Medicare Part D claims
4,190 7× vs specialty avg
MIPS final score
75/100
Specialty distribution in New York
How Retina Specialist (Ophthalmology) Physician compares to other specialties among New York providers
MIPS score not measured
CMS assigned a neutral 75/100 threshold
CMS did not publish any Quality, Cost, Promoting Interoperability, or Improvement Activities category score for this clinician. This administrative threshold is not comparable with the national average of clinicians whose MIPS score was measured.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1902895998 |
|---|---|
| Specialty | Retina Specialist (Ophthalmology) Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 10/21/2005 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
75
Final Score
CMS neutral threshold · not measured
Reporting: Individual
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Alan Uliss, M.D.. To verify Alan Uliss, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Alan Uliss, M.D. - brand share 44.0%
Retina Specialist (Ophthalmology) Physician average
44% brand-name claims vs 56% generic, on 4,190 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
4,190
Total Claims
$720K
Total Drug Cost
831
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 8,129.667
- Total Day Supply
- 236,390
- Brand vs Generic
- 44% brand / 56% generic
- Brand Drug Cost
- $649K
- Generic Drug Cost
- $72K
Patient Demographics
- Average Patient Age
- 77.5 years
- Avg HCC Risk Score
- 1.53
- Gender Split
- 66% female / 34% male
- Age Distribution
- <65: 33, 65-74: 285, 75-84: 327, 85+: 186
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Alan Uliss, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Ketorolac Trometha…
Ketorolac Tromethamine
799 claims
- Latanoprost
Latanoprost
633 claims
- Fluorometholone
Fluorometholone
386 claims
- Dorzolamide-Timolol 304
Dorzolamide-Timolol
304 claims
- Timolol Maleate 201
Timolol Maleate
201 claims
- Brimonidine Tartrate 191
Brimonidine Tartrate
191 claims
- Restasis 166
Restasis
166 claims
- Lumigan 161
Lumigan
161 claims
| Drug | Claims |
|---|---|
| Ketorolac Tromethamine | 799 |
| Latanoprost | 633 |
| Fluorometholone | 386 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 304 |
| Timolol Maleate | 201 |
| Brimonidine Tartrate | 191 |
| Restasis Cyclosporine | 166 |
| Lumigan Bimatoprost | 161 |
| Polymyxin B Sul-Trimethoprim Polymyxin B Sulf/Trimethoprim | 117 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 83 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Retina Specialist (Ophthalmology) Physician in NY →
All providers in New York →
Compare specialties →
Retina Specialist (Ophthalmology) Physician Overview
How Alan Uliss, M.D. fits within the Retina Specialist (Ophthalmology) Physician landscape nationally.
983
Retina Specialist (Ophthalmology) Physician Providers in US
48
States with Retina Specialist (Ophthalmology) Physician
593
Avg Claims per Provider
Alan Uliss, M.D.'s 4,190 claims are above the specialty average of 593.
Nationwide Retina Specialist (Ophthalmology) Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Uliss, both outside New York so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (75 here).
Same NPPES enumeration year (2005)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Retina Specialist (Ophthalmology) Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Uliss.
One of 74 Retina Specialist (Ophthalmology) Physician providers enrolled in New York, 5 are shown here.
Dr. Rami Abu Sbeit
M.D.
Cooperstown, NY
Dr. Steven Agemy
M.D.
New York, NY
Dr. John Alexander
MD
East Meadow, NY
Dr. Louis Angioletti
M.D.
New York, NY
Dr. Nazanin Barzideh
M.D.
Carle Place, NY
Compare Retina Specialist (Ophthalmology) Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Alan Uliss, M.D.'s specialty? ▼
Alan Uliss, M.D. specializes in Retina Specialist (Ophthalmology) Physician and practices in Forest Hills, New York. Credentials: M.D..
How much does Alan Uliss, M.D. prescribe under Medicare Part D? ▼
In 2024, Alan Uliss, M.D. wrote 4,190 Medicare Part D claims totaling $720K in drug costs for 831 beneficiaries.
What is Alan Uliss, M.D.'s Medicare quality score? ▼
Alan Uliss, M.D. has a CMS MIPS Final Score of 75/100. CMS published no Quality, Promoting Interoperability, Improvement Activity or Cost score for this clinician, so the final score is the neutral performance threshold CMS assigns rather than a measured result. The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Alan Uliss, M.D. located? ▼
Alan Uliss, M.D. is located at 11011 72ND AVE, Forest Hills, NY, 11375. Phone: (718) 575-8434.
What is Alan Uliss, M.D.'s NPI number? ▼
Alan Uliss, M.D.'s National Provider Identifier (NPI) is 1902895998, issued on 10/21/2005.
Does Alan Uliss, M.D. prescribe more brand-name or generic drugs? ▼
Alan Uliss, M.D.'s prescribing is 44% brand-name and 56% generic drugs by claim count, with $649K in brand drug costs.
How many Retina Specialist (Ophthalmology) Physician providers are there in the US? ▼
There are 983 Retina Specialist (Ophthalmology) Physician providers across 48 states in the US. The average Retina Specialist (Ophthalmology) Physician provider writes 593 Medicare Part D claims per year.
What drugs does Alan Uliss, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Alan Uliss, M.D.'s most frequently prescribed drugs include Ketorolac Tromethamine, Latanoprost, Fluorometholone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Alan Uliss, M.D. accept Medicare? ▼
Alan Uliss, M.D. appears in CMS Medicare data with 4,190 Part D claims and 831 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Alan Uliss, M.D.'s credentials? ▼
Alan Uliss, M.D.'s NPI is 1902895998 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.